Nkarta to Participate in an Upcoming Investor Conference
Nkarta (Nasdaq: NKTX), a biopharmaceutical company focused on engineered natural killer (NK) cell therapies, has announced its upcoming participation in the 7th Annual Evercore HealthCONx Conference. The company will participate in a fireside chat scheduled for December 4, 2024, at 2:10 p.m. ET.
The event will be accessible through a live webcast on Nkarta's website investor section, with a replay available for approximately 90 days following the presentation.
Nkarta (Nasdaq: NKTX), un'azienda biofarmaceutica focalizzata sulle terapie con cellule natural killer (NK) ingegnerizzate, ha annunciato la sua prossima partecipazione alla 7ª Conferenza Annuale Evercore HealthCONx. L'azienda parteciperà a una chiacchierata informale prevista per il 4 dicembre 2024, alle 14:10 ora orientale.
L'evento sarà accessibile tramite un webcast dal vivo nella sezione investitori del sito web di Nkarta, con una riproduzione disponibile per circa 90 giorni dopo la presentazione.
Nkarta (Nasdaq: NKTX), una empresa biofarmacéutica centrada en las terapias con células asesinas naturales (NK) ingenierizadas, ha anunciado su próxima participación en la 7ª Conferencia Anual Evercore HealthCONx. La empresa participará en una charla informal programada para el 4 de diciembre de 2024, a las 2:10 p.m. ET.
El evento será accesible a través de un webcast en vivo en la sección de inversores del sitio web de Nkarta, con una repetición disponible durante aproximadamente 90 días después de la presentación.
Nkarta (Nasdaq: NKTX), 엔지니어링된 자연 살해(NK) 세포 요법에 중점을 둔 생명공학 회사가 제7회 연례 Evercore HealthCONx 컨퍼런스에 참가한다고 발표했습니다. 회사는 2024년 12월 4일 오후 2시 10분 ET에 예정된 화상 대화에 참여할 예정입니다.
이 이벤트는 Nkarta 웹사이트의 투자자 섹션에서 라이브 웨비나를 통해 접근 가능하며, 프레젠테이션 후 약 90일 동안 재방송이 가능합니다.
Nkarta (Nasdaq: NKTX), une société biopharmaceutique spécialisée dans les thérapies par cellules tueuses naturelles (NK) ingénierées, a annoncé sa prochaine participation à la 7ème Conférence Annuelle Evercore HealthCONx. L'entreprise participera à une discussion informelle prévue pour le 4 décembre 2024, à 14h10 ET.
L'événement sera accessible via un webcast en direct sur la section investisseurs du site web de Nkarta, avec une rediffusion disponible pendant environ 90 jours après la présentation.
Nkarta (Nasdaq: NKTX), ein biopharmazeutisches Unternehmen, das sich auf ingenieurtechnisch hergestellte natürliche Killer (NK) Zelltherapien konzentriert, hat seine bevorstehende Teilnahme an der 7. jährlichen Evercore HealthCONx-Konferenz bekannt gegeben. Das Unternehmen wird an einem informellen Gespräch teilnehmen, das für den 4. Dezember 2024, um 14:10 Uhr ET, geplant ist.
Die Veranstaltung wird über ein Live-Webcast auf der Investorenseite der Nkarta-Website zugänglich sein, mit einer Wiederholung, die etwa 90 Tage nach der Präsentation verfügbar sein wird.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
7th Annual Evercore HealthCONx Conference
December 4, 2024
2:10 p.m. ET – fireside chat
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com
FAQ
When is Nkarta (NKTX) presenting at the Evercore HealthCONx Conference 2024?
How can I watch Nkarta's (NKTX) Evercore HealthCONx Conference presentation?
What type of therapies does Nkarta (NKTX) develop?
